NIH Guide: Weekly Index for July 2, 2021

Funding Opportunities

• Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
  (PA-21-268)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Library of Medicine
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  Office of the Director, NIH
  National Center for Advancing Translational Sciences
  John E. Fogarty International Center
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): A change of recipient organization request must be made before the anticipated start date at the new organization and preferably several months in advance
• NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed)
  (PAR-21-204)
  National Eye Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Research on Interventions that Promote the Careers of Individuals in the Biomedical Research Enterprise (R01 Clinical Trial Not Allowed)
  (PAR-21-269)
  National Institute of General Medical Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
• Exploratory Studies to Investigate the Mechanisms of Interrelationship between Sleep and Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans Required)
  (RFA-DA-22-029)
  National Institute on Drug Abuse
  Application Receipt Date(s): October 14, 2021
• Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R01 Clinical Trial Not Allowed)
  (RFA-DE-22-003)
  National Institute of Dental and Craniofacial Research
  National Cancer Institute
  Application Receipt Date(s): November 18, 2021
• Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R21 Clinical Trial Not Allowed)
  (RFA-DE-22-004)
  National Institute of Dental and Craniofacial Research
  National Cancer Institute
  Application Receipt Date(s): November 18, 2021